DK0969821T3 - Pellets, der har en kerne coatet med et antifungalt middel og en polymer - Google Patents

Pellets, der har en kerne coatet med et antifungalt middel og en polymer

Info

Publication number
DK0969821T3
DK0969821T3 DK98919155T DK98919155T DK0969821T3 DK 0969821 T3 DK0969821 T3 DK 0969821T3 DK 98919155 T DK98919155 T DK 98919155T DK 98919155 T DK98919155 T DK 98919155T DK 0969821 T3 DK0969821 T3 DK 0969821T3
Authority
DK
Denmark
Prior art keywords
pellets
polymer
antifungal agent
core coated
coated
Prior art date
Application number
DK98919155T
Other languages
English (en)
Inventor
Roger Petrus Gerebe Vandecruys
Paul Marie Victor Gilis
Jozef Peeters
Conde Valentin Florent Vict De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0969821T3 publication Critical patent/DK0969821T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK98919155T 1997-03-26 1998-03-18 Pellets, der har en kerne coatet med et antifungalt middel og en polymer DK0969821T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200914 1997-03-26
PCT/EP1998/001773 WO1998042318A1 (en) 1997-03-26 1998-03-18 Pellets having a core coated with an antifungal and a polymer

Publications (1)

Publication Number Publication Date
DK0969821T3 true DK0969821T3 (da) 2003-09-15

Family

ID=8228147

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98919155T DK0969821T3 (da) 1997-03-26 1998-03-18 Pellets, der har en kerne coatet med et antifungalt middel og en polymer

Country Status (30)

Country Link
EP (1) EP0969821B1 (da)
JP (1) JP3608800B2 (da)
KR (1) KR100520936B1 (da)
CN (1) CN1206984C (da)
AP (1) AP1227A (da)
AT (1) ATE241969T1 (da)
AU (1) AU734248B2 (da)
BG (1) BG64434B1 (da)
BR (1) BR9806174A (da)
CA (1) CA2269501C (da)
CY (1) CY2384B1 (da)
CZ (1) CZ295502B6 (da)
DE (1) DE69815316T2 (da)
DK (1) DK0969821T3 (da)
EE (1) EE03904B1 (da)
ES (1) ES2201485T3 (da)
HU (1) HU224217B1 (da)
ID (1) ID21477A (da)
IL (1) IL129575A (da)
NO (1) NO325102B1 (da)
NZ (1) NZ335364A (da)
OA (1) OA11162A (da)
PL (1) PL190566B1 (da)
PT (1) PT969821E (da)
RU (1) RU2218153C2 (da)
SI (1) SI0969821T1 (da)
SK (1) SK284813B6 (da)
TR (1) TR199900990T2 (da)
UA (1) UA60318C2 (da)
WO (1) WO1998042318A1 (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1104291T3 (da) 1998-07-17 2006-01-16 Janssen Pharmaceutica Nv Pelleter med en kerne, som er coatet med et antisvampemiddel og en polymer
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
DK1163234T3 (da) 1999-03-24 2006-02-27 Scherer Technologies Inc R P Farmaceutiske formuleringer med forbedret vandoplöselighed
KR100432949B1 (ko) * 2000-06-13 2004-05-31 코오롱제약주식회사 생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
EP1370543B1 (en) 2001-02-14 2006-10-25 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
EP1397367A2 (en) 2001-04-09 2004-03-17 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
US7622490B2 (en) 2001-05-11 2009-11-24 Tibotec Pharmaceuticals, Ltd. Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
WO2002100407A1 (en) * 2001-06-12 2002-12-19 Smartrix Technologies Inc. Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US7763641B2 (en) 2001-12-21 2010-07-27 Tibotec Pharmaceuticals Ltd. Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
CA2485903C (en) 2002-05-17 2011-08-16 Tibotec Pharmaceuticals Ltd. Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
NZ538714A (en) 2002-08-14 2007-03-30 Tibotec Pharm Ltd Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors
KR100557680B1 (ko) * 2002-11-23 2006-03-07 한국유나이티드제약 주식회사 이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법
DK1438960T4 (da) * 2003-01-14 2013-03-25 Cimex Pharma Ag Sammensætning af itraconazol dispergeret i en hydrofil polymer med forhøjet biotilgængelighed
DK1438961T4 (da) * 2003-01-14 2014-11-17 Acino Pharma Ag Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
EP1651192A1 (en) 2003-08-06 2006-05-03 Nirmal Mulye Pharmaceutical composition containing water soluble drug
CA2531766C (en) 2003-09-11 2012-11-27 Tibotec Pharmaceuticals Ltd. Entry inhibitors of the hiv virus
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
AR048650A1 (es) 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
AU2005244121B2 (en) 2004-05-07 2012-01-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
MXPA06013315A (es) 2004-05-17 2007-02-02 Tibotec Pharm Ltd 1,5-dihidro-pirido[3,2-b]indol-2-onas 4-sustituidas.
TW200607502A (en) 2004-05-17 2006-03-01 Tibotec Pharm Ltd 6, 7, 8, 9-substituted 1-phenyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
KR20070015608A (ko) 2004-05-17 2007-02-05 티보텍 파마슈티칼즈 리미티드 1-헤테로사이클일-1,5-디히드로-피리도[3,2-ｂ]인돌-2-온
RU2008143342A (ru) 2006-04-03 2010-05-10 Тиботек Фармасьютикалз Лтд. (Ie) 3, 4-дигидроимидазо(4, 5-b)пиридин-5-оны, ингибирующие вич(hiv)
KR20090065524A (ko) * 2006-09-04 2009-06-22 파나세아 바이오테크 리미티드 프로그래머블 부력전달기술
KR100809903B1 (ko) * 2006-09-05 2008-03-06 주식회사유한양행 안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
JP2008280254A (ja) * 2007-05-08 2008-11-20 Everest Pharm Industrial Co Ltd 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
US8313527B2 (en) 2007-11-05 2012-11-20 Allergan, Inc. Soft prosthesis shell texturing method
JP5745855B2 (ja) 2007-11-28 2015-07-08 セコイア、ファーマシューティカルズ、インコーポレイテッドＳｅｑｕｏｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． シトクロムｐ４５０ ２ｄ６を阻害するための組成物および方法
CA2716348C (en) 2008-02-21 2017-04-04 Sequoia Pharmaceuticals, Inc. Diamide inhibitors of cytochrome p450
US9050184B2 (en) 2008-08-13 2015-06-09 Allergan, Inc. Dual plane breast implant
US8877822B2 (en) 2010-09-28 2014-11-04 Allergan, Inc. Porogen compositions, methods of making and uses
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
US9205577B2 (en) 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
GB2479213B (en) 2010-04-01 2013-07-10 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
CN102971018B (zh) * 2010-05-11 2016-02-03 阿勒根公司 致孔剂组合物、制备方法及用途
US11202853B2 (en) 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
US8679279B2 (en) 2010-11-16 2014-03-25 Allergan, Inc. Methods for creating foam-like texture
CN102100678B (zh) * 2011-02-18 2012-10-17 天津力生制药股份有限公司 伊曲康唑硫酸盐微丸及其制备方法
AU2013359158B2 (en) 2012-12-13 2018-08-02 Allergan, Inc. Device and method for making a variable surface breast implant
US10092392B2 (en) 2014-05-16 2018-10-09 Allergan, Inc. Textured breast implant and methods of making same
KR102600541B1 (ko) * 2016-01-20 2023-11-08 테라비다, 인코포레이티드 다한증을 치료하기 위한 방법 및 조성물
MX2020010673A (es) * 2018-04-16 2020-10-28 Bristol Myers Squibb Co Formulaciones de apixaban.
CN114767636B (zh) * 2022-04-11 2023-11-07 苏州中化药品工业有限公司 伊曲康唑微丸、制备方法及伊曲康唑微丸胶囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
USH672H (en) * 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
EP0374531B1 (en) * 1988-12-22 1994-05-04 American Cyanamid Company Method for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the periodontal pocket, composition of matter therefor and apparatus for the administration thereof
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
CA2258683C (en) * 1996-06-28 2007-07-31 Schering Corporation Oral composition comprising a triazole antifungal compound

Also Published As

Publication number Publication date
IL129575A (en) 2004-06-20
NO992114L (no) 1999-08-26
EP0969821B1 (en) 2003-06-04
HUP0002056A3 (en) 2001-01-29
CN1206984C (zh) 2005-06-22
HUP0002056A2 (hu) 2000-12-28
CZ295502B6 (cs) 2005-08-17
AP9901516A0 (en) 1999-06-30
DE69815316T2 (de) 2004-04-29
SK54499A3 (en) 2000-01-18
HU224217B1 (hu) 2005-06-28
SK284813B6 (sk) 2005-12-01
PT969821E (pt) 2003-10-31
NO325102B1 (no) 2008-02-04
UA60318C2 (uk) 2003-10-15
EE9900453A (et) 2000-04-17
KR100520936B1 (ko) 2005-10-17
JP3608800B2 (ja) 2005-01-12
AP1227A (en) 2003-11-24
CN1244796A (zh) 2000-02-16
PL190566B1 (pl) 2005-12-30
KR20000052971A (ko) 2000-08-25
OA11162A (en) 2003-04-16
ID21477A (id) 1999-06-17
RU2218153C2 (ru) 2003-12-10
SI0969821T1 (en) 2003-10-31
JP2001520663A (ja) 2001-10-30
BR9806174A (pt) 1999-10-19
HK1022840A1 (en) 2000-08-25
AU7210798A (en) 1998-10-20
EE03904B1 (et) 2002-12-16
EP0969821A1 (en) 2000-01-12
CY2384B1 (en) 2004-06-04
ATE241969T1 (de) 2003-06-15
NZ335364A (en) 2000-08-25
BG64434B1 (en) 2005-02-28
IL129575A0 (en) 2000-02-29
NO992114D0 (no) 1999-04-30
PL335542A1 (en) 2000-04-25
CZ139899A3 (cs) 1999-10-13
BG103356A (en) 2000-03-31
TR199900990T2 (xx) 1999-10-21
AU734248B2 (en) 2001-06-07
CA2269501C (en) 2005-11-08
CA2269501A1 (en) 1998-10-01
WO1998042318A1 (en) 1998-10-01
ES2201485T3 (es) 2004-03-16
DE69815316D1 (de) 2003-07-10

Similar Documents

Publication Publication Date Title
NO992114L (no) Pellets som har en kjerne belagt med et antisoppmiddel og en polymer
DK1104291T3 (da) Pelleter med en kerne, som er coatet med et antisvampemiddel og en polymer
DK0658103T3 (da) Korn med en kerne coatet med et antifungalt middel og en polymer
NO20005630D0 (no) Mikro-laser-kuler og strukturer, og tilhörende fremgangsmåter
NO980450D0 (no) Induserbar herbicidresistens
DK1009597T3 (da) Barberingssystem, der har skaft og udskiftelig kassette
FI956337A7 (fi) Absorboiva ydin, jolla on parantuneet nesteenkäsittelyominaisuudet
FI956322L (fi) Elektroninen laite, jossa on saranarakenne
DE69938207D1 (de) Anzeigegerät mit aktiver Matrix
BR0012206B1 (pt) artigo fotocrâmico revestido e artigo fotocrâmico.
DE69916184D1 (de) Rundballenpresse mit Garnwickelkontrole
DE69520717D1 (de) Kassette, Aufbewahrungsbehälter, und Etikett für dergleiche Kassette und Aufbewahrungsbehälter
DE69932639D1 (de) Datenintegritätsüberwachung
PT1074551E (pt) Fenilpirazois com actividade herbicida
DK0719092T3 (da) Tyggegummi med hård coating og forbedret holdbarhed, med xylitol- og polyolcoating
DK199900207A (da) Tilslutningsliste og på en tilslutningsliste påsættelig overspændingsbeskyttelsesmagasin
PL358909A1 (en) Pellets having a core coated with a lipid lowering agent and a polymer
NO992690D0 (no) Nye calpainer, fremstilling og anvendelse derav
IT1303229B1 (it) Dispositivo per lavorazione a truciolo e relativo sopporto perutensile.
FI964447A7 (fi) Kytkin, jolla on kontrolloidut nousu- ja laskuominaisuudet
NO995027D0 (no) Datamelding gjennom telefonnett uten oppkoblingstid
ID30440A (id) Baut friksi dengan inti fleksible
ITMO970122A0 (it) Attrezzo particolarmente per allenamento ginnico sportivo e relativo u so.
FI962923L (fi) Uusi glykoproteiini-isomuotokoostumus, jolla on follikkelia stimuloiva aktiivisuus
ES1038641Y (es) Estructura integral para palancas, trampolines y similares.